Skip to content

News / Analytics / Reviews

Stock Market Analysis
Corporate News
Financial News

Tilray Brands in charts: Cannabis business struggles in FQ1 ’25

Posted on October 10, 2024 by wpadmin

Posted in Corporate NewsTagged TLRY

Post navigation

Previous: Tilray sees better days for cannabis amid U.S. presidential race

Next: Medtronic: Undervalued Dividend Aristocrat With High Margins

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Search

Recent Posts

Movie theater stocks get spooked by Netflix’s $72B deal for Warner Bros. assets
Market Voices: Warren slams WBD-Netflix deal, US warns on NATO
ETFs with heavy Netflix and Warner Bros. allocations are set to ride the media shakeup
Nvidia reveals its biggest expansion to CUDA since its 2006 launch
Sen. Warner says Netflix buying Warner Bros. is `anti-monoply nightmare’

Recent Comments

Tom Ford on Affirm: A Genuine Innovation In Finance
Tim Donohue on Tilray Brands Q3 Earnings: Another Disappointing Quarter
PAUL URSUL on Lucid Troubles Keep Building
Warpaint on AT&T: A Classic Value Trap
Tyrion Lannister on Microsoft: AI, A Product Development Boon

Archives

Categories

Corporate News
Financial News
Stock Market Analysis

Powered By WordPress | Newsmagify